Actively Recruiting

Phase 2
Age: 21Years - 75Years
MALE
ID07601646

Phase 2 Clinical Trial of ST-04 Intraurethral Paste for Erectile Dysfunction

Led by Ryan Flannigan, MD · Updated on 2026-05-22

83

Participants Needed

1

Research Sites

4 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating a new treatment called ST-04, a mucoadhesive intraurethral polymer suspension of alprostadil, for adult males with erectile dysfunction (ED). This Phase 2 trial aims to assess the effectiveness of three different dose levels of ST-04, with or without sildenafil, to improve erectile function compared to the participants' baseline. ST-04 is designed to deliver alprostadil directly inside the urethra to promote penile tumescence and erection. Participants will receive up to three escalating doses of ST-04 over a 12-week period, with a maximum of 11 administrations. Dose levels include 500 mcg, 1000 mcg, and 1500 mcg of ST-04, which may be given with or without sildenafil. Each dose is dispersed along the urethra forming a hydrogel that adheres to the lining to achieve its effect. During the study, participants will undergo assessments including the International Index of Erectile Function (IIEF) questionnaire to measure changes in erectile function at baseline and 1 month after each dose level. Additional evaluations include the Erectile Hardness Scale, Sexual Encounter Profile, and the percentage of successful erection onset within 30 minutes of application. Safety will be monitored through the recording of adverse events. The total study duration includes up to 12 weeks of treatment with regular follow-up visits.

CONDITIONS

Brief Title

A Single-Arm, Dose Escalation of an Intraurethral Alprostadil Paste for Erectile Dysfunction

Who Can Participate

Age: 21Years - 75Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Have had a confirmed clinical diagnosis of erectile dysfunction for more than three months based on the IIEF
  • Have failed PDE5 inhibitor therapy due to inability to achieve an erection with adequate rigidity for penetrative sex
  • Ability to take oral medication such as sildenafil and willingness to follow the study intervention regimen
  • Engaged in a heterosexual relationship for a minimum of six months
  • Male participants aged 21 to 75 years
Not Eligible

You will not qualify if you...

  • History of unstable medical or psychiatric conditions that may affect study completion
  • Spinal cord injury or penile anatomical abnormalities
  • Cardiovascular conditions preventing sexual activity such as NYHA Class II or higher, angina, uncontrolled congestive heart failure, or severe coronary artery disease
  • History of myocardial infarction, stroke, or life-threatening arrhythmia within six months before enrollment
  • Use of anti-androgens or oral/injectable androgens
  • Documented or known orthostatic hypotension
  • Use of oral, topical, or sublingual nitrates within three months before enrollment
  • Hepatic failure classified as Child-Pugh Class C or renal failure with eGFR below 30
  • Inadequate response to previous intracavernosal injection therapy
  • Presence of Peyronie's disease or meatal stenosis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Up to 12 weeks depending on dose level

Participants receive escalating doses of ST-04 intraurethral paste to evaluate its effectiveness and safety for erectile dysfunction.

Visits approximately every 4 weeks during treatment at Weeks 4, 8, and 12

Trial Site Locations

Total: 1 location

1

Vancouver Prostate Centre

Vancouver, British Columbia, Canada, V5Z1M9

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Similar Trials

A Potential Relationship Between Treatment With Tyrosine Kin...

Chronic Myelocytic Leukemia

Actively Recruiting

1 location

Traditional Medicine Pattern Distribution in Patients With E...

Erectile Dysfunctions

Actively Recruiting

1 location

Daily Tadalafil 5 mg Combined With On-Demand Sildenafil 100 ...

Erectile Dysfunctions

Actively Recruiting

11 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here